4//SEC Filing
SAHAREK JOHN P. 4
Accession 0001493152-24-036244
CIK 0001360214other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:26 PM ET
Size
9.3 KB
Accession
0001493152-24-036244
Insider Transaction Report
Form 4
HARROW, INC.HROW
SAHAREK JOHN P.
CEO & President, ImprimisRx
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-09-11−90,000→ 0 totalExercise: $7.37Exp: 2025-02-01→ Common Stock (90,000 underlying) - Exercise/Conversion
Common stock
2024-09-11$7.37/sh+90,000$663,300→ 344,803 total - Tax Payment
Common stock
2024-09-11$41.37/sh−45,140$1,867,442→ 299,663 total
Footnotes (1)
- [F1]The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option.
Documents
Issuer
HARROW, INC.
CIK 0001360214
Entity typeother
Related Parties
1- filerCIK 0001632091
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:26 PM ET
- Size
- 9.3 KB